MS4A6A and Alzheimer disease: Given that rs636317-T is predicted to disrupt a CTCF binding site, a likely scenario is that this SNP may destroy one of the two anchor CTCF binding sites in a chromatin loop, leading to altered chromatin architecture and activity in the locus, which in turn leads to upregulation of MS4A6A expression and increased AD risk.